The three day pilgrimage to Lough Derg runs from June 28th to June 30th next. The crew will leave Drogheda and pick up in ...

Leo Daily Horoscope Today, July 07, 2025: Something better begins with surrender Neeraj Dhankher / TOI Astrology / Jul 07, 2025, 03:00 IST ...

Telangana's health minister has announced the establishment of cancer care centres in every district to address the alarming rise in cancer cases, with 50,000 to 55,000 new cases reported annually ...

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have conducted a comprehensive study of Qatar’s pioneering national cancer care and research strategy, highlighting the significant ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

A.C. Camargo Cancer Center, a leading oncology treatment center in São Paulo, Brazil recognized for its history of innovation, has deployed more than 2,000 state-of-the-art video surveillance ...

A second opinion in any profession is the best practice. That's why Karmanos Cancer Institute implemented a streamlined process to provide patients with second opinions within seven days of an ...

The factor most associated with cancer is unavoidable: aging. Older adults with cancer benefit from a geriatric assessment before making treatment decisions, but this is still not routine care.

Candidates in the Virginia special election to succeed the late Rep. Gerald E. Connolly are facing a sprint to the June 28 firehouse primary.

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020.

Pope Leo XIV wore a Chicago White Sox hat while making a public appearance at the Vatican. Born Robert Prevost, the pope hails from Chicago and is a lifelong fan.

A.C. Camargo has deployed more than 2,000 video surveillance cameras throughout the center’s corridors, complex care units, and parking lots. A.C. Camargo Cancer Center, a leading oncology ...